Roquefort Therapeutics hail LYRAMID identifying lead compounds to
Roquefort Therapeutics PLC (LSE:ROQ) chairman Stephen West talks to Proactive London about LYRAMID, their research…
Read More...
Read More...
Recover your password.
A password will be e-mailed to you.